Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by trade2win2on Jul 24, 2012 9:22am
359 Views
Post# 20145643

Options granted-who would of thought!!!!!!

Options granted-who would of thought!!!!!!

Well I guess we now see why this price was sold down to 14 cents. Someone knew they were out seeking some cash.. Will be interesting to see who the CERTAIN ELIGIBLE PARTICIPANTS are....well done management, well done!!!!!! Not. Stuck in this dog.....

CALGARY, ALBERTA--(Marketwire - July 24, 2012) - Santa Maria Petroleum Inc. (formerly Quetzal Energy Ltd.) ("Santa Maria" or the "Company") (TSX VENTURE:SMQ) announces that it has granted stock options ("Options") to purchase an aggregate of 2,355,000 common shares of the Company at a price of
.16 per share to certain eligible participants. The 2,355,000 Options are exercisable for a period of five years from the date of grant and vest as to one-third on each of the first, second and third anniversaries of the date grant. As of the date hereof, the Company has granted Options to purchase an aggregate of 4,503,759 common shares of the Company.

Bullboard Posts